SharpyGLP-1 for Seniors: Is It Safe Over 65? Medicare and Risks
GLP-1 drugs like Wegovy and Zepbound have no upper age limit on their US labels, and the Zepbound label reports no overall difference in safety or effectiveness for adults 65 and older. Fewer people over 75 were studied, and the Wegovy label notes more hip and pelvis fractures in people 75 and older in its heart trial, so dehydration, falls and muscle loss deserve extra care. Medicare can now cover these drugs through the $50 GLP-1 Bridge or Part D for heart, sleep apnea or diabetes uses, and Sharpy helps older adults keep their muscle with one protein target and one 20-minute workout a day.
Are GLP-1 drugs safe for seniors? For many adults over 65 they can be, under a doctor's care. The US labels for Wegovy, Zepbound, Ozempic and Mounjaro have no upper age limit, and the Zepbound label reports no overall difference in safety or effectiveness between people 65 and older and younger adults. The catch is that fewer people over 75 were studied, and older bodies handle dehydration, muscle loss and falls less well. Here is what the labels actually say, what Medicare covers now, and how to stay strong while you lose weight.
Is GLP-1 safe for seniors? What the labels say
The best place to start is section 8.5, "Geriatric Use," in each drug's official prescribing information. This is the part of the label where the FDA reports how older adults did in the trials.
| Drug and trial | Age 65 to 74 on the drug | Age 75 and older on the drug | What the label adds |
|---|---|---|---|
| Wegovy shot, weight trials | 233 people (9%) | 23 people (1%) | Few patients 75+ studied |
| Wegovy pill 25 mg, weight trial | 16 people (8%) | 5 people (2%) | Small numbers |
| Wegovy shot, SELECT heart trial | 2,656 people (30%) | 703 people (8%) | People 75+ had more hip and pelvis fractures than on placebo |
| Zepbound, weight trials | 226 people (9%) age 65+ | 13 people (0.5%) | No overall differences in safety or effectiveness for 65+ |
| Zepbound, sleep apnea trials | Too few to tell | Too few to tell | Not enough people 65+ to know if they respond differently |
Two things stand out. First, the heart trial for Wegovy included thousands of people over 65, so there is real data for that group. Second, data on people over 75 is thin. That does not mean the drugs are unsafe at 75 or 80. It means your doctor has less trial evidence to lean on and may want to watch you more closely.
Is there a max age for GLP-1?
No. All four labels are written for adults and none sets an upper age. Searches like "glp-1 for over 70" and "max age for glp-1" usually come from people who were told they are "too old." Age alone is not a reason on the label. Your other conditions, medicines and goals are what matter.
The real risks of GLP-1 after 65
These warnings are in the labels for everyone, but they carry more weight as we age.
| Risk | Why it matters more after 65 | What helps |
|---|---|---|
| Dehydration and kidney injury | Nausea, vomiting and diarrhea can drain fluids; the labels warn of acute kidney injury from fluid loss | Sip fluids all day; tell your doctor fast if you cannot keep fluids down |
| Muscle loss | Older adults already lose muscle each year; fast weight loss can speed it up | Protein at every meal and strength work 2 to 3 times a week |
| Falls and fractures | Less muscle plus dizziness raises fall risk; the Wegovy label notes more hip and pelvis fractures in people 75+ in its heart trial | Leg and balance training; stand up slowly |
| Gallbladder problems | The labels list acute gallbladder disease, which is linked to fast weight loss | Report pain in the upper right belly, fever or yellow skin |
| Low blood sugar | Risk goes up if you also take insulin or a sulfonylurea | Your doctor may adjust those medicines |
| Surgery and sedation | The labels warn of food staying in the stomach during anesthesia | Tell every surgeon and dentist you take a GLP-1 |
Many seniors take several medicines. Bring a full list, including vitamins, to your prescriber. Our guide on Ozempic and kidney disease covers what to know if your kidneys are already weaker.
What is the best GLP-1 for seniors?
There is no single best one. Each drug is approved for different things, and that often decides the choice.
| Drug | Form | Approved uses that matter for older adults |
|---|---|---|
| Wegovy (semaglutide) | Weekly shot or daily pill | Weight loss; the shot also lowers the risk of heart attack, stroke and heart death in adults with heart disease and obesity or overweight |
| Zepbound (tirzepatide) | Weekly shot | Weight loss; moderate to severe sleep apnea in adults with obesity |
| Ozempic (semaglutide) | Weekly shot | Type 2 diabetes |
| Mounjaro (tirzepatide) | Weekly shot | Type 2 diabetes |
| Foundayo (orforglipron) | Daily pill | Weight loss |
In the SELECT trial, published in the New England Journal of Medicine, semaglutide cut major heart events by 20% in adults 45 and older with heart disease and overweight or obesity but no diabetes. For a senior with a past heart attack or stroke, that can tip the decision. Our Zepbound sleep apnea guide covers the sleep apnea route.
GLP-1 for seniors on Medicare
For years, Medicare drug plans could not cover drugs used only for weight loss. That has changed in two ways.
- The Medicare GLP-1 Bridge. From July 1, 2026 to December 31, 2027, people with Medicare drug coverage who qualify by BMI (35 or more, or lower with certain conditions) can get Wegovy, Foundayo or the Zepbound KwikPen for a $50 monthly copay. Your prescriber files the prior authorization. Our Medicare GLP-1 Bridge guide walks through every step.
- Part D for medical uses. Part D plans can cover GLP-1s for type 2 diabetes, and for uses like heart risk or sleep apnea, at your plan's own copay and rules.
Medicare open enrollment runs October 15 to December 7, 2026. If you have Original Medicare with no drug plan, you need one to use either route. A November 2026 study found few Medicare plans actually list Wegovy for heart disease or MASH; see does Medicare cover Wegovy for each route.
How older adults can protect muscle on GLP-1
This is the part that makes the biggest difference to your daily life. Weight loss on these drugs is not all fat. In a body scan substudy of the STEP 1 trial, lean mass made up close to 40% of the weight lost. For a 40-year-old that is a concern. For a 75-year-old, it can mean trouble climbing stairs or getting up from a chair. Our guide on sarcopenia and GLP-1 explains the science.
Two habits help most:
- Protein. The PROT-AGE expert group suggests 1.0 to 1.2 grams of protein per kilogram of body weight a day for healthy adults over 65, and 1.2 to 1.5 for many with chronic illness. For a 180-pound person, that is roughly 80 to 100 grams a day. If you have kidney disease, ask your doctor for your number. Our protein target guide shows how to set it.
- Strength work. Two or three short sessions a week of chair squats, wall push-ups, step-ups and band rows. Our resistance training guide has a simple plan.
Sharpy puts both into one place: a daily protein target, one 20-minute workout you can do at home, and a Shape Score that shows whether you are losing fat, not muscle.
A GLP-1 diet for seniors on low-appetite days
Appetite can drop a lot. Older adults also feel thirst less. A few ideas:
- Eat protein first: eggs, Greek yogurt, cottage cheese, fish, tofu or a protein shake.
- Keep meals small and soft, like soups with beans or shredded chicken.
- Set a reminder to drink a glass of water with every meal and between meals.
- Skip greasy and very sweet foods, which can make nausea worse.
Questions to ask your doctor
- Is a GLP-1 right for my heart, blood sugar, joints or sleep apnea?
- Which of my current medicines could interact or need a change?
- How will we check my kidneys, fluids and strength?
- What weight loss pace is safe for me?
If you have a history of an eating disorder, very low body weight, or serious symptoms like severe belly pain, talk to your doctor before starting.
The bottom line
GLP-1 drugs have no age cap, and adults 65 and older did about as well as younger adults in the trials the labels report. The real work for seniors is protecting muscle, bones and fluids while the weight comes off. Talk to your prescriber about which drug fits your health and your Medicare coverage. Then let Sharpy help you hit your protein and stay strong. Sharpy is not a medical device and is not affiliated with Novo Nordisk, Eli Lilly or Medicare.
For more on the bigger picture, see our guide on GLP-1 and aging.
Sources
- Wegovy (semaglutide) prescribing information, revised 6/2026, DailyMed
- Zepbound (tirzepatide) prescribing information, revised 8/2026, DailyMed
- Lincoff AM et al. Semaglutide and cardiovascular outcomes in obesity without diabetes (SELECT), NEJM 2023
- Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1), NEJM 2021
- Bauer J et al. Evidence-based recommendations for optimal dietary protein intake in older people (PROT-AGE), JAMDA 2013
- Medicare GLP-1 Bridge, Medicare.gov
Questions people ask
Is GLP-1 safe for seniors?
For many older adults, yes, under a doctor's care. The Zepbound label says no overall differences in safety or effectiveness were seen between patients 65 and older and younger adults. The bigger risks after 65 are dehydration that can hurt the kidneys, muscle loss, and falls, so your prescriber should weigh your health as a whole.
Is there a max age for GLP-1?
No. The US labels for Wegovy, Zepbound, Ozempic and Mounjaro are for adults and do not set an upper age limit. But far fewer people over 75 were in the trials. In the Zepbound weight trials, only 13 people (0.5%) on the drug were 75 or older.
What is the best GLP-1 for seniors?
There is no single best one. It depends on your goals and health. Wegovy shot is the only one with an approved heart-risk use for people with heart disease, Zepbound is approved for sleep apnea, and Ozempic and Mounjaro are for type 2 diabetes. Your doctor picks based on your conditions, other medicines and coverage.
Does Medicare cover GLP-1 for seniors?
Often, now. From July 1, 2026 to December 31, 2027, the Medicare GLP-1 Bridge covers Wegovy, Foundayo and the Zepbound KwikPen for weight loss at a $50 monthly copay if you qualify by BMI and have Medicare drug coverage. Part D plans can also cover GLP-1s for type 2 diabetes, sleep apnea or heart risk, at the plan's own copay.
Should I take a GLP-1 over 65?
That is a decision for you and your doctor. Good questions to ask: will it help my heart, joints, blood sugar or sleep apnea, what other medicines could interact, and how will we protect my muscle and bones while I lose weight?
Can you take GLP-1 over 70?
Yes, the labels allow it for adults of any age. In the Wegovy heart trial, 703 people on the drug (8%) were 75 or older. Older adults may need closer checks on fluids, kidney function and strength, which your prescriber can plan.
What should seniors eat on GLP-1?
Protein first at every meal, plenty of fluids, and soft, easy foods on low-appetite days. Experts on aging suggest about 1.0 to 1.2 grams of protein per kilogram of body weight a day for healthy older adults, and more for some people with illness. Ask your doctor if you have kidney disease.